Pre-Congress Workshops

 

WORKSHOP B: PASSIVE IMMUNITY FOR INFECTIOUS DISEASES

 

Panel discussion
April 14, 10:00 - 5:30

 

Anti-Infective Immunotherapies: Should there really be a distinction between passive and active immunization when responding to diseases and infections therapeutically? Join this workshop to understand how anti-infective immunotherapies are increasingly combined and the role of both passive and active immunization in future.
 
  • Scientific rationale & landscape of antibodies in preclinical and clinical development for infectious diseases
     
  • Anti-fungal Immunotherapy – Candida vaccine
     
  • Anti-fungal immunotherapy – Cryptococcus Neoformans vaccine
     
  • RSV and bacterial (Sa and Pa) prophylactic monoclonals in development
     
  • Development and testing of a human IgG1 monoclonal antibody to the broadly conserved microbial surface polysaccharide, PNAG
     
  • Bacterial mAbs and vaccine approaches
     
  • MAbs against viruses
     
  • Designing and Engineering antibodies to mutable protein targets
     
  • Regulatory Strategy and guidance on developing anti-infective immunotherapies
 
 
 
 
Sumathi Nambiar Sumathi Nambiar, Director, Division Of Aniti-Infective Products, FDA
 
 
 
 
 
 
 

 

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington

 

To Sponsor Or Exhibit

Marc Rhys-Evans
marc.rhys-evans@terrapinn.com
+44 20 7827 5945

 

 

 

To Register

Tayyab Abbasi
tayyab.abbasi@terrapinn.com
+44 20 7092 1210

 

 

 

Press Relations

Karina Kusova
karina.kusova@terrapinn.com
+44 20 7092 1071